» Articles » PMID: 26727951

Multi-phenotypic Role of Serum Response Factor in the Gastrointestinal System

Overview
Date 2016 Jan 6
PMID 26727951
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Serum response factor (SRF) is a master transcription factor of the actin cytoskeleton that binds to highly conserved CArG boxes located within the majority of smooth muscle cell (SMC)-restricted promoters/enhancers. Although most studies of SRF focus on skeletal muscle, cardiac muscle, and vascular SMCs, SRF research has recently expanded into the gastrointestinal (GI) system. Genome scale analyses of GI SMC transcriptome and CArG boxes (CArGome) have identified new SRF target genes. In addition to circular and longitudinal smooth muscle layers, SRF is also expressed in GI mucosa and cancers. In the GI tract, SRF is the central regulator of genes involved in apoptosis, dedifferentiation, proliferation, and migration of cells. Since SRF is the cell phenotypic modulator, it may play an essential role in the development of myopathy, hypertrophy, ulcers, gastric and colon cancers within the GI tract. Given the multifunctional role displayed by SRF in the digestive system, SRF has received more attention emerging as a potential therapeutic target. This review summarizes the findings in SRF research pertaining to the GI tract and provides valuable insight into future directions.

Citing Articles

Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer.

Liang L, Kong C, Li J, Liu G, Wei J, Wang G Microbiome. 2024; 12(1):274.

PMID: 39731152 PMC: 11681701. DOI: 10.1186/s40168-024-01987-7.


Identification of transcriptional regulators and signaling pathways mediating postnatal rumen growth and functional maturation in cattle.

Pokhrel B, Tan Z, Jiang H J Anim Sci. 2024; 103.

PMID: 39656757 PMC: 11781194. DOI: 10.1093/jas/skae367.


Novel bioinformatic approaches show the role of driver genes in the progression of cervical cancer: An in-silico study.

Yari A, Aghbash P, Bayat M, Lahouti S, Jalilzadeh N, Zadeh L Heliyon. 2024; 10(22):e40179.

PMID: 39634417 PMC: 11616557. DOI: 10.1016/j.heliyon.2024.e40179.


The role of m6A RNA methylation in cancer metabolism.

An Y, Duan H Mol Cancer. 2022; 21(1):14.

PMID: 35022030 PMC: 8753874. DOI: 10.1186/s12943-022-01500-4.


RNA m6A methylation regulators in ovarian cancer.

Guo J, Zheng J, Zhang H, Tong J Cancer Cell Int. 2021; 21(1):609.

PMID: 34794452 PMC: 8600856. DOI: 10.1186/s12935-021-02318-8.


References
1.
Wang D, Chang P, Wang Z, Sutherland L, Richardson J, Small E . Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105(7):851-62. DOI: 10.1016/s0092-8674(01)00404-4. View

2.
Bae J, Noh S, Kim K, Jang K, Chung M, Kim D . Serum response factor induces epithelial to mesenchymal transition with resistance to sorafenib in hepatocellular carcinoma. Int J Oncol. 2013; 44(1):129-36. DOI: 10.3892/ijo.2013.2154. View

3.
Long X, Tharp D, Georger M, Slivano O, Lee M, Wamhoff B . The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem. 2009; 284(48):33671-82. PMC: 2785209. DOI: 10.1074/jbc.M109.050419. View

4.
Zhang S, Garcia-Gras E, Wycuff D, Marriot S, Kadeer N, Yu W . Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem. 2005; 280(19):19115-26. DOI: 10.1074/jbc.M413793200. View

5.
Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, Concordet J . Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol. 2004; 24(12):5281-9. PMC: 419888. DOI: 10.1128/MCB.24.12.5281-5289.2004. View